# Abiraterone

## Zytiga 250mg

##### 臨採

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OZYT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Indications        | Prostate cancer: Treatment of metastatic， castration-resistant prostate cancer (in combination with prednisone).                                                                                                                                                                                                                                                                                                                                                                                                           |
| Dosing             | [Metastatic castration-resistant prostate cancer] 1000 mg orally once daily with prednisone 5 mg orally twice daily.[Metastatic castration-sensitive prostate cancer] 1000 mg orally once daily with prednisone 5 mg orally once daily.Patients receiving ZYTIGA should also receive a gonadotropin-releasinghormone (GnRH) analog concurrently or should have had bilateral orchiectomy. ZYTIGA must be taken on an empty stomach with water at least 1 hour before or 2 hours after a meal. Do not crush or chew tablets. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity. Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | UTI， hypokalaemia， hypertriglyceridaemia， cardiac failure， angina pectoris， arrhythmia， atrial fibrillation， tachycardia， HTN， increased ALT， peripheral oedema， fractures.                                                                                                                                                                                                                                                                                                                                      |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

